Human Peripheral Blood Mononucleocyte Derived Myeloid Committed Progenitor Cells Mitigate H-ARS by Exosomal Paracrine...

Area of Science:

• Hematology
• Regenerative Medicine
• Radiation Biology

Background:

• Radiation exposure severely damages hematopoietic stem and progenitor cells, impairing bone marrow regeneration and leading to life-threatening complications.
• Current treatments like bone marrow transplantation are limited by HLA matching requirements, posing challenges for mass casualty scenarios.
• Effective interventions are needed to counteract radiation-induced hematopoietic toxicity and improve survival rates.

Purpose of the Study:

• To investigate the potential of human peripheral blood mononuclear cell-derived myeloid committed progenitor cells in mitigating radiation-induced bone marrow toxicity.
• To evaluate the efficacy of these progenitor cells as an alternative to bone marrow transplantation in a preclinical model.
• To explore the therapeutic mechanisms, including the role of extracellular vesicles (sEVs), in radiation injury recovery.

Main Methods:

• Isolation and characterization of myeloid committed progenitor cells from human peripheral blood.
• Administration of these cells to mice post-radiation exposure.
• Assessment of hematopoietic recovery, survival rates, and graft-versus-host disease (GVHD) development.
• Analysis of secreted extracellular vesicles (sEVs) and their cargo.

Main Results:

• Myeloid committed progenitor cells significantly mitigated radiation-induced bone marrow toxicity and improved survival in mice.
• Therapeutic effects were observed even when cells were administered up to 24 hours after radiation exposure.
• Allogeneic transplantation of these cells did not result in GVHD.
• Transplanted cells released sEVs containing regenerative and immune-modulatory factors that counteracted radiation damage.

Conclusions:

• Human peripheral blood-derived myeloid committed progenitor cells represent a promising therapeutic strategy for acute radiation syndrome.
• These cells provide an accessible, 'off-the-shelf' allogeneic treatment option, bypassing the need for HLA matching.
• The regenerative paracrine signaling, particularly via sEVs, is a key mechanism for mitigating complex radiation-induced injuries.